SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 7
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 6 7
|
presentations:
1 to
50 of
316
|
ADVANCES IN MOLECULAR VIROLOGY
Wesley I. Sundquist
University of Utah, Salt Lake City, UT, USA
ADVANCES IN HIV IMMUNOLOGY AND VACCINES
Richard A. Koup
National Institutes of Health, Bethesda, MD, USA
ISSUES IN MATERNAL, INFANT, AND CHILD HEALTH
Hermione Lyall
Imperial College Healthcare NHS Trust, London, United Kingdom
ADVANCES IN HIV PREVENTION
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
ADVANCES IN HIV CURE
Nicolas Chomont
Université de Montréal, Montreal, QC, Canada
PUTTING ANALYSIS INTO ANALYTICAL TREATMENT INTERRUPTIONS (ABSTRACT
7)
Lu (Summer) Zheng
Harvard T. H. Chan School of Public Health, Boston, MA, USA
ADVANCING FROM PHASE II TO PHASE III: NAVIGATING THE LAND OF EXPECTATIONS (ABSTRACT
8)
Patrick PJ Phillips
University of California San Francisco, San Francisco, CA, USA
NONINFERIORITY COMPLEX (ABSTRACT
9)
Jeffrey Scott Murray
Food and Drug Administration, Silver Spring, MD, USA
INCLUSION OF DIVERSE POPULATIONS IN TRIALS (ABSTRACT
10)
Mark Harrington
Treatment Action Group, New York, NY, USA
SHAPING VACCINES WITH DNA ORIGAMI (ABSTRACT
3)
Mark Bathe
Massachusetts Institute of Technology, Cambridge, MA, USA
CONCEPTS IN RESERVOIR MEASUREMENTS (ABSTRACT
4)
Janet M. Siliciano
The Johns Hopkins University, Baltimore, MD, USA
CHARTING GENOME-WIDE INTEGRATION (ABSTRACT
5)
Mary F Kearney
National Cancer Institute, Frederick, MD, USA
SINGLE-CELL EPIGENETICS: COLORING IMMUNE CELLS WITH A RICH PALETTE OF HISTONE MARKS (ABSTRACT
6)
Alex J Kuo
Stanford University, Stanford, CA, USA
WHEN AT THIRD YOU DON'T SUCCEED (ABSTRACT
11)
David L. Wyles
Denver Health and Hospital Authority, Denver, CO, USA
'A' CASE TO REMEMBER: HEPATITIS A - MANAGING AN OLD VIRUS IN NEW POPULATIONS AT RISK (ABSTRACT
12)
Darcy Wooten
University of California San Diego, San Diego, CA, USA
HEPATOCELLULAR CARCINOMA (ABSTRACT
13)
Susanna Naggie
Duke University, Durham, NC, USA
NONALCOHOLIC STEATOHEPATITIS (ABSTRACT
14)
Kathleen E Corey
Massachusetts General Hospital, Boston, MA, USA
OPENING SESSION HOST
Sharon L. Hillier
University of Pittsburgh, Pittsburgh, PA, USA
THE ANCIENT AND MODERN ORIGINS OF HIV (ABSTRACT
15)
Michael Emerman
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
TRANSLATING HIV SCIENCE INTO POPULATION IMPACT: A REALITY CHECK FROM THE FRONTLINE (ABSTRACT
16)
Alex Godwin Coutinho
Independent Consultant,, Uganda
HIV CURE FROM BENCH TO BEDSIDE (ABSTRACT
17)
Sharon R. Lewin
University of Melbourne, Melbourne, Victoria, Australia
UNIVERSAL TEST AND TREAT (UTT): LESSONS FROM THE PAST AND FOR THE FUTURE (ABSTRACT
18)
Kevin M. De Cock
Centers for Disease Control and Prevention, Nairobi, Kenya
INDEX FACTORS INCREASE PARTNER NOTIFICATION YIELD FOR KENYAN PEOPLE WHO INJECT DRUGS (ABSTRACT
42)
Brandon Guthrie
University of Washington, Seattle, WA, USA
COMMUNITY-BASED MULTIMONTH DISPENSING OF ART: A CLUSTER RANDOMISED TRIAL IN LESOTHO (ABSTRACT
43)
Betty Bawuba Tukei
Right to Care, Maseru, Lesotho
AN MHEALTH CHW INTERVENTION TRIAL IN AN HIV HYPERENDEMIC COMMUNITY IN RAKAI, UGANDA (ABSTRACT
44)
Larry W Chang
Johns Hopkins University School of Medicine, Baltimore, MD, USA
IMPROVED TIME IN CARE AND VIRAL SUPPRESSION WITH STREAMLINED CARE IN THE SEARCH STUDY (ABSTRACT
45)
Matthew D Hickey
University of California San Francisco, San Francisco, CA, USA
COLLABORATIVE DATA-TO-CARE MODEL IMPROVES HIV CARE OUTCOMES IN PLWH IN PHILADELPHIA (ABSTRACT
46)
Kathleen Anne Brady
Philadelphia Department of Public Health, Philadelphia, PA, USA
POPULATION-LEVEL VIREMIA PREDICTS HIV INCIDENCE ACROSS UNIVERSAL TEST & TREAT STUDIES (ABSTRACT
47)
Maya L Petersen
University of California, Berkeley, Berkeley, CA, USA
DECREASING COMMUNITY VIREMIA IS ASSOCIATED WITH DECREASING HIV INCIDENCE IN AUSTRALIA (ABSTRACT
48)
Denton James Callander
UNSW Sydney, Sydney, NSW, Australia
COMMUNITY ART INCREASES VIRAL SUPPRESSION AND ELIMINATES DISPARITIES FOR AFRICAN MEN (ABSTRACT
49)
Ruanne V Barnabas
University of Washington, Seattle, WA, USA
SINGLE-CELL GENOMIC ANALYSIS OF BLOOD AND CSF T CELLS IN HIV+ AND HIV– ADULTS (ABSTRACT
27)
Shelli Farhadian
Yale School of Medicine, New Haven, CT, USA
GREATER BURDEN OF INTRACRANIAL ARTERIAL-WALL ENHANCEMENT IN PERSONS LIVING WITH HIV (ABSTRACT
28)
Felicia C Chow
University of California San Francisco, San Francisco, CA, USA
PET IMAGING OF SYNAPTIC DENSITY IN HIV: PRELIMINARY FINDINGS FROM A PILOT STUDY (ABSTRACT
29)
Julian Weiss
Yale University, New Haven, CT, USA
HIV-INFECTED MACROPHAGES EVADE NK CELL-MEDIATED KILLING WHILE DRIVING INFLAMMATION (ABSTRACT
30)
Kiera L Clayton
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
HIV DNA DETECTED IN IMMUNE CELL SUBSETS IN CSF DURING ART (ABSTRACT
31)
Joshua Charles Cyktor
University of Pittsburgh, Pittsburgh, PA, USA
EFFECTS OF HIV AND AGING ON RESTING-STATE NETWORKS (ABSTRACT
32)
Patrick Luckett
Washington University in St Louis, St Louis, MO, USA
MYELIN CONTENT IS ELEVATED IN VIROLOGICALLY UNSUPPRESSED PEOPLE LIVING WITH HIV (ABSTRACT
33)
Dimitre Tomov
Washington University, St Louis, MO, USA
CABOTEGRAVIR + RILPIVIRINE EVERY 2 MONTHS IS NONINFERIOR TO MONTHLY: ATLAS-2M STUDY (ABSTRACT
34)
Edgar Turner Overton
University of Alabama, Birmingham, AL, USA
PROSPECTIVE ENHANCED MONITORING OF DOLUTEGRAVIR-BASED FIRST LINE IN MALAWI (ABSTRACT
35)
Elvis Temfack
Medecins Sans Frontieres, Blantyre, Malawi
RANDOMIZED SWITCH TO B/F/TAF IN AFRICAN AMERICAN ADULTS WITH HIV (ABSTRACT
36)
Debbie P Hagins
Chatham CARE Center, Savannah, GA, USA
IMPACT OF ANTI-PD-1 AND ANTI-CTLA-4 ON THE HIV RESERVOIR IN VIVO: THE AMC-095 STUDY (ABSTRACT
37)
Thomas Aagaard Rasmussen
University of Melbourne, Melbourne, Victoria, Australia
A RANDOMIZED TRIAL OF THE IMPACT OF 3BNC117 AND ROMIDEPSIN ON THE HIV-1 RESERVOIR (ABSTRACT
38)
Ole Schmeltz Søgaard
Aarhus University Hospital, Aarhus N, Denmark
SAFETY & PHARMACOKINETICS OF GS-9722 IN HIV-NEGATIVE PARTICIPANTS AND PEOPLE WITH HIV (ABSTRACT
39)
Peter Ruane
Peter J Ruane, MD Inc, Los Angeles, CA, USA
SAFETY AND ANALYTIC TREATMENT INTERRUPTION OUTCOMES OF VESATOLIMOD IN HIV CONTROLLERS (ABSTRACT
40)
Devi Sengupta
Gilead Sciences, Foster City, CA, USA
DURABLE HIV-1 ANTIBODY PRODUCTION IN HUMANS AFTER AAV8-MEDIATED GENE TRANSFER (ABSTRACT
41)
Joseph P Casazza
National Institutes of Health, USA, Bethesda, MD, USA
MECHANISMS OF PSGL-1 AND CD43 RESTRICTION OF HIV INFECTION OF CD4 T CELLS (ABSTRACT
19)
Yuntao Wu
George Mason University, Manassas, VA, USA
STRUCTURAL ANALYSES OF A BOUND ANTI-CD4 ADNECTIN INHIBITOR OF HIV-1 (ABSTRACT
20)
David Wensel
ViiV Healthcare, Branford, CT, USA
SERINC3/5 PERTURB HIV MEMBRANE FUSION POST-HEMIFUSION AT FUSION-PORE DILATION STEPS (ABSTRACT
21)
Amanda E Ward
University of Virginia, Charlottesville, VA, USA
CRISPR-INDUCED MUTAGENESIS POINTS TOWARD A ROLE OF TRN-SR2 IN HIV NUCLEAR IMPORT (ABSTRACT
22)
Frauke Christ
Katholieke University Leuven, Leuven, Belgium
NUCLEAR UNCOATING OF HIV-1 OCCURS NEAR SITES OF INTEGRATION (ABSTRACT
23)
Ryan C Burdick
National Cancer Institute, Frederick, MD, USA
|
<< first | < prev
page:
of 7
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 6 7
|
presentations:
1 to
50 of
316
|
